{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-142414","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.691757+00:00","generated_at":"2026-06-25T23:47:37.926599+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Organogenesis appoints Michele Korfin and Gilberto Quintero to board as independent directors","bullets":["Michele Korfin appointed as independent director; brings experience from Gamida Cell, Kite Pharma, Celgene.","Gilberto Quintero appointed as independent director; serves as Chief Quality Officer at Kimberly-Clark, formerly at Cardinal Health.","Each director receives $55,000 annual retainer and 23,913 RSUs vesting May 3, 2023.","Board expands to 11 members, with majority now independent under Nasdaq standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-142414","json":"https://secwatch.observer/filing/0001193125-22-142414.json","markdown":"https://secwatch.observer/filing/0001193125-22-142414.md","text":"https://secwatch.observer/filing/0001193125-22-142414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/0001193125-22-142414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/d716496d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:47:37.926599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2bff879ff6","claim":"Gilberto Quintero was appointed as independent director at Organogenesis Holdings Inc..","evidence_excerpt":"the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/0001193125-22-142414-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"},{"claim_id":"41ea6e3679","claim":"Michele I. Korfin was appointed as independent director at Organogenesis Holdings Inc..","evidence_excerpt":"the Company announced that each of Michele I. Korfin and Gilberto Quintero had been appointed by the board of directors to serve as an independent director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/0001193125-22-142414-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}